Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3586)
All Articles published online
|
Feb 1, 2004 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiao WH, Liu WW. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 2004; 10(3): 376-380 [PMID: 14760761 DOI: 10.3748/wjg.v10.i3.376] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i3/376.htm |
| Number | Citing Articles |
| 1 |
Quek Choon Lau, Erna Raja, Manuel Salto-Tellez, Qiang Liu, Kosei Ito, Masafumi Inoue, Thomas Choudary Putti, Marie Loh, Tun Kiat Ko, Canhua Huang, Kapil N. Bhalla, Tao Zhu, Yoshiaki Ito, Saraswati Sukumar. RUNX3 Is Frequently Inactivated by Dual Mechanisms of Protein Mislocalization and Promoter Hypermethylation in Breast Cancer. Cancer Research 2006; 66(13): 6512 doi: 10.1158/0008-5472.CAN-06-0369
|
| 2 |
Xin-Zi Chi, Jeung-Ook Yang, Kwang-Youl Lee, Kosei Ito, Chohei Sakakura, Qing-Lin Li, Hye-Ryun Kim, Eun-Jeung Cha, Yong-Hee Lee, Atsushi Kaneda, Toshikazu Ushijima, Wun-Jae Kim, Yoshiaki Ito, Suk-Chul Bae. RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor β-Activated SMAD. Molecular and Cellular Biology 2005; 25(18): 8097 doi: 10.1128/MCB.25.18.8097-8107.2005
|
| 3 |
K-S Lee, Y-S Lee, J-M Lee, K Ito, S Cinghu, J-H Kim, J-W Jang, Y-H Li, Y-M Goh, X-Z Chi, H Wee, H-W Lee, A Hosoya, J-H Chung, J-J Jang, J K Kundu, Y-J Surh, W-J Kim, Y Ito, H-S Jung, S-C Bae. Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer. Oncogene 2010; 29(23): 3349 doi: 10.1038/onc.2010.79
|
| 4 |
Tomomitsu Tahara, Tomiyasu Arisawa. Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation. Expert Review of Molecular Diagnostics 2012; 12(5): 489 doi: 10.1586/erm.12.38
|
| 5 |
M Suzuki, H Shigematsu, D S Shames, N Sunaga, T Takahashi, N Shivapurkar, T Iizasa, E P Frenkel, J D Minna, T Fujisawa, A F Gazdar. DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. British Journal of Cancer 2005; 93(9): 1029 doi: 10.1038/sj.bjc.6602837
|
| 6 |
Karsten Schulmann, Anca Sterian, Agnes Berki, Jing Yin, Fumiaki Sato, Yan Xu, Andreea Olaru, Suna Wang, Yuriko Mori, Elena Deacu, James Hamilton, Takatsugu Kan, Mark J Krasna, David G Beer, Margaret S Pepe, John M Abraham, Ziding Feng, Wolff Schmiegel, Bruce D Greenwald, Stephen J Meltzer. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 2005; 24(25): 4138 doi: 10.1038/sj.onc.1208598
|
| 7 |
Dominic Chih-Cheng Voon, Jean Paul Thiery. RUNX Proteins in Development and Cancer. Advances in Experimental Medicine and Biology 2017; 962: 471 doi: 10.1007/978-981-10-3233-2_28
|
| 8 |
Qian‑Qian Gao, Bin Zhou, Xiu‑Zhang Yu, Zhu Zhang, Yan‑Yun Wang, Ya‑Ping Song, Lin Zhang, Hong Luo, Ming‑Rong Xi. Transcriptome changes induced by RUNX3 in cervical cancer cells in�vitro. Oncology Letters 2019; doi: 10.3892/ol.2019.11128
|
| 9 |
W Mueller, C L Nutt, M Ehrich, M J Riemenschneider, A von Deimling, D van den Boom, D N Louis. Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 2007; 26(4): 583 doi: 10.1038/sj.onc.1209805
|
| 10 |
Yun-Mi Goh, Senthilkumar Cinghu, Eileen Tan Hwee Hong, You-Soub Lee, Jang-Hyun Kim, Ju-Won Jang, Ying-Hui Li, Xin-Zi Chi, Kyeong-Sook Lee, Heejun Wee, Yoshiaki Ito, Byung-Chul Oh, Suk-Chul Bae. Src Kinase Phosphorylates RUNX3 at Tyrosine Residues and Localizes the Protein in the Cytoplasm. Journal of Biological Chemistry 2010; 285(13): 10122 doi: 10.1074/jbc.M109.071381
|
| 11 |
Jennifer ZJ Maccani, Devin C Koestler, Eugene Andrés Houseman, Carmen J Marsit, Karl T Kelsey.
Placental DNA Methylation Alterations Associated with Maternal Tobacco Smoking at the
RUNX3
Gene are also Associated with Gestational Age
. Epigenomics 2013; 5(6): 619 doi: 10.2217/epi.13.63
|
| 12 |
Do Youn Park, Hideo Sakamoto, Sandra D. Kirley, Shuji Ogino, Takako Kawasaki, Eunjeong Kwon, Mari Mino-Kenudson, Gregory Y. Lauwers, Daniel C. Chung, Bo R. Rueda, Lawrence R. Zukerberg. The Cables Gene on Chromosome 18q Is Silenced by Promoter Hypermethylation and Allelic Loss in Human Colorectal Cancer. The American Journal of Pathology 2007; 171(5): 1509 doi: 10.2353/ajpath.2007.070331
|
| 13 |
Yutaka Nakanishi, Hidenori Shiraha, Shin-ichi Nishina, Shigetomi Tanaka, Minoru Matsubara, Shigeru Horiguchi, Masaya Iwamuro, Nobuyuki Takaoka, Masayuki Uemura, Kenji Kuwaki, Hiroaki Hagihara, Junichi Toshimori, Hideki Ohnishi, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Takahito Yagi, Kazuhide Yamamoto. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-3
|
| 14 |
P. Pineau, S. Ezzikouri, A. Marchio, M. Benazzouz, E. Cordina, R. Afifi, L. Elkihal, M.T. Khalfallah, H. Mestiri, S. Tebbal, S. Berkane, N. Debzi, H. Triki, A. Dejean, F. Iguer, O. Bahri, A.E.E. Essaid el Feydi, S. Benjelloun. Genomic stability prevails in North-African hepatocellular carcinomas. Digestive and Liver Disease 2007; 39(7): 671 doi: 10.1016/j.dld.2007.03.012
|
| 15 |
Kosei Ito, Qiang Liu, Manuel Salto-Tellez, Takashi Yano, Kotaro Tada, Hiroshi Ida, Canhua Huang, Nilesh Shah, Masafumi Inoue, Andrea Rajnakova, Kum Chew Hiong, Bee Keow Peh, Hwan Chour Han, Tomoko Ito, Ming Teh, Khay Guan Yeoh, Yoshiaki Ito. RUNX3, A Novel Tumor Suppressor, Is Frequently Inactivated in Gastric Cancer by Protein Mislocalization. Cancer Research 2005; 65(17): 7743 doi: 10.1158/0008-5472.CAN-05-0743
|
| 16 |
Xianjue Wang, Ping Wei, Ling Yang, Fangyuan Liu, Xin Tong, Xiaoyu Yang, Liya Su. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3. Chinese Medical Journal 2022; 135(17): 2089 doi: 10.1097/CM9.0000000000001975
|
| 17 |
Eung Jin Shin, Han Jo Kim, Myoung Won Son, Tae Sung Ahn, Hyun Yong Lee, Dae Ro Lim, Sang Byung Bae, Seob Jeon, Hyungjoo Kim, Dongjun Jeong, Moon Soo Lee, Dong-Sun Kim, Jeong Se Noh, Moo-Jun Baek. Epigenetic inactivation of RUNX3 in colorectal cancer. Annals of Surgical Treatment and Research 2018; 94(1): 19 doi: 10.4174/astr.2018.94.1.19
|
| 18 |
Shigetomi Tanaka, Hidenori Shiraha, Yutaka Nakanishi, Shin‐Ichi Nishina, Minoru Matsubara, Shigeru Horiguchi, Nobuyuki Takaoka, Masaya Iwamuro, Junro Kataoka, Kenji Kuwaki, Hiroaki Hagihara, Junichi Toshimori, Hideki Ohnishi, Akinobu Takaki, Shinichiro Nakamura, Kazuhiro Nouso, Takahito Yagi, Kazuhide Yamamoto. Runt‐related transcription factor 3 reverses epithelial–mesenchymal transition in hepatocellular carcinoma. International Journal of Cancer 2012; 131(11): 2537 doi: 10.1002/ijc.27575
|
| 19 |
Tatsuo Yoshizaki, Takayuki Enomoto, Masami Fujita, Yutaka Ueda, Takashi Miyatake, Kazuko Fujiwara, Takahito Miyake, Toshihiro Kimura, Kiyoshi Yoshino, Tadashi Kimura. Frequent inactivation of RUNX3 in endometrial carcinoma. Gynecologic Oncology 2008; 110(3): 439 doi: 10.1016/j.ygyno.2008.05.004
|
| 20 |
Hidenori Shiraha, Shin‐ichi Nishina, Kazuhide Yamamoto. Loss of runt‐related transcription factor 3 causes development and progression of hepatocellular carcinoma. Journal of Cellular Biochemistry 2011; 112(3): 745 doi: 10.1002/jcb.22973
|
| 21 |
Karen Blyth, Ewan R. Cameron, James C. Neil. The runx genes: gain or loss of function in cancer. Nature Reviews Cancer 2005; 5(5): 376 doi: 10.1038/nrc1607
|
| 22 |
Feng Gao, Canhua Huang, Mei Lin, Zhi Wang, Jun Shen, Haiyuan Zhang, Lu Jiang, Qianming Chen. Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. Journal of Cancer Research and Clinical Oncology 2009; 135(5): 739 doi: 10.1007/s00432-008-0508-x
|
| 23 |
Zhe Jin, Ya-Xin Han, Xiao-Rui Han. Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma. Journal of Molecular Histology 2013; 44(6): 645 doi: 10.1007/s10735-013-9511-x
|
| 24 |
Manish Mani Subramaniam, Jason Yongsheng Chan, Khay Guan Yeoh, Timothy Quek, Kosei Ito, Manuel Salto-Tellez. Molecular pathology of RUNX3 in human carcinogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2009; 1796(2): 315 doi: 10.1016/j.bbcan.2009.07.004
|
| 25 |
Yuewu Yang, Zhiqiang Ye, Zengcheng Zou, Gemin Xiao, Gangjian Luo, Hongzhi Yang. Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma. Tumor Biology 2014; 35(10): 10333 doi: 10.1007/s13277-014-2329-7
|
| 26 |
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
|
| 27 |
Takashi Yano, Kosei Ito, Hiroshi Fukamachi, Xin-Zi Chi, Hee-Jun Wee, Ken-ichi Inoue, Hiroshi Ida, Philippe Bouillet, Andreas Strasser, Suk-Chul Bae, Yoshiaki Ito. The RUNX3 Tumor Suppressor Upregulates Bim in Gastric Epithelial Cells Undergoing Transforming Growth Factorβ-Induced Apoptosis. Molecular and Cellular Biology 2006; 26(12): 4474 doi: 10.1128/MCB.01926-05
|
| 28 |
Kin Wai Lai, King Xin Koh, Marie Loh, Kotaro Tada, Manish Mani Subramaniam, Xn Yii Lim, Aparna Vaithilingam, Manuel Salto-Tellez, Barry Iacopetta, Yoshiaki Ito, Richie Soong. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. European Journal of Cancer 2010; 46(8): 1456 doi: 10.1016/j.ejca.2010.01.036
|
| 29 |
Diego F. Calvisi. Of Mice and Men: the Nonrandom Genomic Instability in Hepatocarcinogenesis Δσ. Hepatology 2011; 53(3): 723 doi: 10.1002/hep.24205
|
| 30 |
Yasusei Kudo, Takaaki Tsunematsu, Takashi Takata. Oncogenic role of RUNX3 in head and neck cancer. Journal of Cellular Biochemistry 2011; 112(2): 387 doi: 10.1002/jcb.22967
|
| 31 |
Dongjun Jeong, Hyungjoo Kim, Aeli Ryu, Jaegun Sunwoo, Seung Choi, Gye Nam, Seob Jeon. Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8915
|
| 32 |
Yumi Nagahama, Mika Ishimaru, Mitsuhiko Osaki, Toshiaki Inoue, Akihiro Maeda, Chisato Nakada, Masatsugu Moriyama, Kenzo Sato, Mitsuo Oshimura, Hisao Ito. Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN‐1. Cancer Science 2008; 99(1): 23 doi: 10.1111/j.1349-7006.2007.00650.x
|
| 33 |
Mizuho Ichikawa, Yasuhito Arai, Masayuki Haruta, Shinsuke Furukawa, Tadashi Ariga, Tadashi Kajii, Yasuhiko Kaneko. Meiosis error and subsequent genetic and epigenetic alterations invoke the malignant transformation of germ cell tumor. Genes, Chromosomes and Cancer 2013; 52(3): 274 doi: 10.1002/gcc.22027
|
| 34 |
Lindsay C Spender, Hannah J Whiteman, Claudio Elgueta Karstegl, Paul J Farrell. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 2005; 24(11): 1873 doi: 10.1038/sj.onc.1208404
|
| 35 |
Suk-Chul Bae, Yong Hee Lee. Phosphorylation, acetylation and ubiquitination: The molecular basis of RUNX regulation. Gene 2006; 366(1): 58 doi: 10.1016/j.gene.2005.10.017
|
| 36 |
Bo Tang, Jian Du, Yang Li, Fang Tang, Zhenran Wang, Songqing He. EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0271-6
|
| 37 |
Kunio Araki, Mitsuhiko Osaki, Yumi Nagahama, Toshiki Hiramatsu, Hiroshige Nakamura, Shigetsugu Ohgi, Hisao Ito. Expression of RUNX3 protein in human lung adenocarcinoma: Implications for tumor progression and prognosis. Cancer Science 2005; 96(4): 227 doi: 10.1111/j.1349-7006.2005.00033.x
|
| 38 |
Wei Chen, Manuel Salto‐Tellez, Nallasivam Palanisamy, Kumaresan Ganesan, Qingsong Hou, Lay Keng Tan, Lang Hiong Sii, Kosei Ito, Benita Tan, Jeanie Wu, Andrew Tay, Kok Chai Tan, Erik Ang, Bien Keem Tan, Puay Hoon Tan, Yoshiaki Ito, Patrick Tan. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes, Chromosomes and Cancer 2007; 46(3): 288 doi: 10.1002/gcc.20411
|
| 39 |
Faisal Saeed Khan, Ijaz Ali, Ume Kalsoom Afridi, Muhammad Ishtiaq, Rashid Mehmood. Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics. Hepatology International 2017; 11(1): 45 doi: 10.1007/s12072-016-9743-4
|
| 40 |
Milena Krajnović, Bojana Kožik, Ana Božović, Snežana Jovanović-Ćupić. Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications. Cells 2023; 12(18): 2303 doi: 10.3390/cells12182303
|
| 41 |
Wun-Jae Kim, Eun-Jung Kim, Pildu Jeong, Changyi Quan, Jiyeon Kim, Qing-Lin Li, Jeong-Ook Yang, Yoshiaki Ito, Suk-Chul Bae.
RUNX3 Inactivation by Point Mutations and Aberrant DNA Methylation in Bladder Tumors. Cancer Research 2005; 65(20): 9347 doi: 10.1158/0008-5472.CAN-05-1647
|
| 42 |
Jianbo Zheng, Yanhui Mei, Guangsheng Zhai, Ning Zhao, Dongsheng Jia, Yidong Fan. Downregulation of RUNX3 has a poor prognosis and promotes tumor progress in kidney cancer. Urologic Oncology: Seminars and Original Investigations 2020; 38(9): 740.e11 doi: 10.1016/j.urolonc.2020.05.021
|
| 43 |
Toshiaki Mori, Shuji Nomoto, Katsumi Koshikawa, Tsutomu Fujii, Mitsuru Sakai, Yoko Nishikawa, Soichiro Inoue, Shin Takeda, Tetsuya Kaneko, Akimasa Nakao. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver International 2005; 25(2): 380 doi: 10.1111/j.1478-3231.2005.1059.x
|
| 44 |
J Gisin, A Perren, M Bawohl, W Jochum. Rare allelic imbalances, but no mutations of thePRDX1gene in human hepatocellular carcinomas. Journal of Clinical Pathology 2005; 58(11): 1229 doi: 10.1136/jcp.2004.024679
|
| 45 |
Michał Bereza, Mateusz Dembiński, Agnieszka E. Zając, Jakub Piątkowski, Monika Dudzisz-Śledź, Piotr Rutkowski, Anna M. Czarnecka. Epigenetic Abnormalities in Chondrosarcoma. International Journal of Molecular Sciences 2023; 24(5): 4539 doi: 10.3390/ijms24054539
|
| 46 |
Kazunori Hasegawa, Shujiro Yazumi, Manabu Wada, Toshiharu Sakurai, Masaya Kida, Junichi Yamauchi, Hiroshi Hisatsune, Shinsuke Tada, Hiroshi Ida, Yuenn Nakase, Chohei Sakakura, Akeo Hagiwara, Tsutomu Chiba. Restoration of RUNX3 enhances transforming growth factor‐β‐dependent p21 expression in a biliary tract cancer cell line. Cancer Science 2007; 98(6): 838 doi: 10.1111/j.1349-7006.2007.00460.x
|
| 47 |
JUNRO KATAOKA, HIDENORI SHIRAHA, SHIGERU HORIGUCHI, HIROAKI SAWAHARA, DAISUKE UCHIDA, TERUYA NAGAHARA, MASAYA IWAMURO, HIROKI MORIMOTO, YASUTO TAKEUCHI, KENJI KUWAKI, HIDEKI ONISHI, SHINICHIRO NAKAMURA, AKINOBU TAKAKI, KAZUHIRO NOUSO, TAKAHITO YAGI, KAZUHIDE YAMAMOTO, HIROYUKI OKADA. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. Oncology Reports 2016; 35(5): 2576 doi: 10.3892/or.2016.4681
|
| 48 |
Seiji Shio, Yuzo Kodama, Hiroshi Ida, Masahiro Shiokawa, Koji Kitamura, Etsuro Hatano, Shinji Uemoto, Tsutomu Chiba. Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis. Cancer Science 2011; 102(4): 776 doi: 10.1111/j.1349-7006.2011.01848.x
|
| 49 |
Yongsheng Tan, Yan Li. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1. Biochemical and Biophysical Research Communications 2015; 466(3): 592 doi: 10.1016/j.bbrc.2015.09.091
|
| 50 |
Satoshi Fujii, Kosei Ito, Yoshiaki Ito, Atsushi Ochiai. Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation. Journal of Biological Chemistry 2008; 283(25): 17324 doi: 10.1074/jbc.M800224200
|
| 51 |
Peng-Jin Mei, Jin Bai, Hui Liu, Chen Li, Yong-Ping Wu, Zheng-Quan Yu, Jun-Nian Zheng. RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration. Journal of Cancer Research and Clinical Oncology 2011; 137(12): 1823 doi: 10.1007/s00432-011-1063-4
|
| 52 |
Naoshi Nishida, Takafumi Nishimura, Takeshi Nagasaka, Iwao Ikai, Goel Ajay, C. Richard Boland. Extensive Methylation Is Associated with β-Catenin Mutations in Hepatocellular Carcinoma: Evidence for Two Distinct Pathways of Human Hepatocarcinogenesis. Cancer Research 2007; 67(10): 4586 doi: 10.1158/0008-5472.CAN-06-3464
|
| 53 |
Sun Hee Lee, Yuk Dong Jung, Young Sun Choi, You Mie Lee. Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget 2015; 6(32): 33269 doi: 10.18632/oncotarget.5037
|
| 54 |
Eun-Jung Kim, Yong-June Kim, Pildu Jeong, Yun-Sok Ha, Suk-Chul Bae, Wun-Jae Kim. Methylation of the RUNX3 Promoter as a Potential Prognostic Marker for Bladder Tumor. Journal of Urology 2008; 180(3): 1141 doi: 10.1016/j.juro.2008.05.002
|
| 55 |
Xueyan Zhang, Hairong He, Xu Zhang, Wenjie Guo, Yueqi Wang. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis. Cancer Investigation 2015; 33(4): 121 doi: 10.3109/07357907.2014.1003934
|